Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

SRTS - Sensus Healthcare, Inc.


IEX Last Trade
7.23
-0.160   -2.213%

Share volume: 5,335
Last Updated: Thu 26 Dec 2024 08:30:13 PM CET
Surgical and Medical Instrument Manufacturing : 1.09%

PREVIOUS CLOSE
CHG
CHG%

$7.39
-0.16
-2.17%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
29%
Profitability 6%
Dept financing 6%
Liquidity 74%
Performance 45%
Company vs Stock growth
vs
Performance
5 Days
-1.02%
1 Month
-21.02%
3 Months
18.26%
6 Months
35.19%
1 Year
172.00%
2 Year
-1.45%
Key data
Stock price
$7.23
P/E Ratio 
16.08
DAY RANGE
$6.88 - $7.39
EPS 
$0.41
52 WEEK RANGE
$2.44 - $9.33
52 WEEK CHANGE
$183.33
MARKET CAP 
106.857 M
YIELD 
N/A
SHARES OUTSTANDING 
16.389 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
BETA 
0.72
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$213,885
AVERAGE 30 VOLUME 
$189,506
Company detail
CEO: Joseph C. Sardano
Region: US
Website: sensushealthcare.com
Employees: 40
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Sensus Healthcare, Inc. manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. SRT-100 is an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers.

Recent news